CTS Announces First Quarter 2022 Results

Delivered solid growth, further advancing diversification strategy

LISLE, Ill., April 28, 2022 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “sense, connect and move” today announced first quarter 2022 results.

“Our solid first quarter results highlight the progress of our diversification strategy and our ability to deliver enhanced profitability, with revenue growing 15% and Adjusted EBITDA margin expanding 350-basis points. Our acquisition of TEWA Sensors in the first quarter and our recently announced agreement to acquire Ferroperm demonstrate our efforts to expand growth of non-transportation end markets and will move this portion of the business closer to 50% of total revenues in the year ahead,” said Kieran O’Sullivan, CEO of CTS Corporation. “Demand remains robust across all end markets. Our strong balance sheet and solid cash flow generation continue to be key competitive advantages as we further execute on our strategic priorities and drive value for our shareholders.”

First Quarter 2022 Results

• Sales were $147.7 million, up 15% year-over-year. Sales to non-transportation end markets increased 30%, and sales to the transportation end market increased 4% over the same period.
• Net income was $20.2 million, or $0.63 per diluted share, compared to $12.0 million, or $0.37 per diluted share, in the first quarter of 2021.
• Adjusted diluted EPS was $0.67, up from $0.46 in the first quarter of 2021.
• Adjusted EBITDA margin was 23.5% compared to 20.0% in the first quarter of 2021.
• Operating cash flow was $19.3 million compared to $20.1 million in the first quarter of 2021.

2022 Guidance

Including the impact of the recent TEWA Sensors acquisition, CTS now expects full year 2022 sales to be in the range of $550 – $580 million, up from the previous guidance of $525 – $550 million and adjusted diluted EPS in the range of $2.20 – $2.45, up from the previous guidance of $2.00 – $2.25. Management continues to carefully evaluate the impact of inflation, supply chain issues, COVID 19-related disruptions in China, and geopolitical risks.

Conference Call and Supplemental Materials

As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EDT) today to discuss the first quarter 2022 financial results. The dial-in number for the U.S. and Canada is 844-200-6205 (+1 929-526-1599, if calling from outside the U.S. or Canada). The passcode is 549088. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://www.ctscorp.com/investors/events-presentations/.

About CTS

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

Safe Harbor

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management’s expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause CTS’ actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: the ultimate impact of the COVID-19 pandemic on CTS’ business, results of operations or financial condition; changes in the economy generally and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions including TEWA Temperature Sensors and Ferroperm Piezoceramics (once closed subject to obtaining regulatory approvals and satisfaction of customary closing conditions); the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; and risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact the conflict between Russia and Ukraine may have on our business, results of operations and financial condition). Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

Non-GAAP Financial Measures

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS’ management believes that non-GAAP financial measures can be useful to investors in analyzing CTS’ financial performance and results of operations over time. CTS recommends that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.

The information included in this press release includes the non-GAAP financial measures of adjusted gross margin, adjusted operating earnings, adjusted EBITDA, adjusted net earnings, adjusted diluted earnings per share, debt to capitalization ratio, controllable working capital ratio, and free cash flow. Many of these non-GAAP financial measures exclude the effect of certain expenses and income not related directly to the underlying performance of CTS’ fundamental business operations.

CTS believes that adjusted gross margins, adjusted operating earnings, adjusted EBITDA, adjusted net earnings and, adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations or were not part of CTS’ business operations during a comparable period.

CTS believes that debt to capitalization ratio is a measurement of financial leverage and provides an insight into the financial structure of CTS and its financial strength. CTS believes the controllable working capital ratio provides an objective measure of the efficiency with which CTS manages its short-term capital needs. CTS believes that free cash flow is a useful measure of its ability to generate cash.

CTS believes that these non-GAAP financial measures are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. Note that CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS’ control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

Contact

Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532 USA
+1 (630) 577-8800
[email protected]

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS – UNAUDITED
(In thousands of dollars, except per share amounts)

		Three Months Ended
		March 31, 2022				March 31, 2021
Net sales		$	147,695			$	128,427
Cost of goods sold			93,355				85,836
Gross margin			54,340				42,591
Selling, general and administrative expenses			21,788				18,325
Research and development expenses			6,194				5,687
Restructuring charges			312				81
Operating earnings			26,046				18,498
Other (expense) income:
Interest expense			(546	)			(555	)
Interest income			180				202
Other income (expense), net			66				(3,356	)
Total other expense, net			(300	)			(3,709	)
Earnings before income taxes			25,746				14,789
Income tax expense			5,507				2,799
Net earnings			20,239				11,990
Earnings per share:
Basic		$	0.63			$	0.37
Diluted		$	0.63			$	0.37
Basic weighted – average common shares outstanding:			32,123				32,319
Effect of dilutive securities			204				301
Diluted weighted – average common shares outstanding:			32,327				32,620
Cash dividends declared per share		$	0.04			$	0.04

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)

		(Unaudited)
		March 31, 2022				December 31, 2021
ASSETS
Current Assets
Cash and cash equivalents		$	126,118			$	141,465
Accounts receivable, net			95,107				82,191
Inventories, net			52,454				49,506
Other current assets			18,366				15,927
Total current assets			292,045				289,089
Property, plant and equipment, net			97,041				96,876
Operating lease assets, net			23,212				21,594
Other Assets
Prepaid pension asset			31,882				49,382
Goodwill			117,524				109,798
Other intangible assets, net			79,849				69,888
Deferred income taxes			23,828				25,415
Other			19,365				2,420
Total other assets			272,448				256,903
Total Assets		$	684,746			$	664,462
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable		$	60,010			$	55,537
Operating lease obligations			3,522				3,393
Accrued payroll and benefits			12,954				18,418
Accrued expenses and other liabilities			38,554				36,718
Total current liabilities			115,040				114,066
Long-term debt			50,000				50,000
Long-term operating lease obligations			22,712				21,354
Long-term pension obligations			6,464				6,886
Deferred income taxes			5,865				5,894
Other long-term obligations			4,487				2,684
Total Liabilities			204,568				200,884
Commitments and Contingencies
Shareholders’ Equity
Common stock			316,496				314,620
Additional contributed capital			41,158				42,549
Retained earnings			511,197				492,242
Accumulated other comprehensive loss			(3,445	)			(4,525	)
Total shareholders’ equity before treasury stock			865,406				844,886
Treasury stock			(385,228	)			(381,308	)
Total shareholders’ equity			480,178				463,578
Total Liabilities and Shareholders’ Equity		$	684,746			$	664,462

CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION – UNAUDITED
(In millions of dollars, except per share amounts)

Adjusted Gross Margin

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Gross margin		$	54.3			$	42.6			$	184.6			$	139.1			$	157.6
Adjustments to reported gross margin:
Inventory fair value step-up		$	0.6			$	—			$	—			$	—			$	—
Adjusted gross margin		$	54.9			$	42.6			$	184.6			$	139.1			$	157.6
Net sales		$	147.7			$	128.4			$	512.9			$	424.1			$	469.0
Adjusted gross margin as a % of net sales			37.2	%			33.2	%			36.0	%			32.8	%			33.6	%

Adjusted Operating Earnings

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Operating earnings		$	26.0			$	18.5			$	76.5			$	45.1			$	53.8
Adjustments to reported operating earnings:
Restructuring charges			0.3				0.1				1.7				1.8				7.4
Environmental charges			0.5				0.2				2.3				2.8				2.3
Legal settlement			—				—				—				—				(0.5	)
Transaction costs			0.5				—				—				0.3				0.7
Inventory fair value step-up			0.6				—				—				—				—
Costs of tax improvement initiatives			—				—				—				—				0.1
Total adjustments to reported operating earnings		$	1.9			$	0.3			$	3.9			$	4.9			$	10.0
Adjusted operating earnings		$	28.0			$	18.8			$	80.4			$	50.0			$	63.8
Net sales		$	147.7			$	128.4			$	512.9			$	424.1			$	469.0
Adjusted operating earnings as a % of net sales			19.0	%			14.6	%			15.7	%			11.8	%			13.6	%

Adjusted EBITDA

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Net earnings (loss)		$	20.2			$	12.0			$	(41.9	)		$	34.7			$	36.1
Depreciation and amortization expense			6.7				6.8				26.9				26.7				24.6
Interest expense			0.5				0.6				2.1				3.3				2.6
Tax expense (benefit)			5.5				2.8				(19.0	)			10.8				14.1
EBITDA			33.0				22.2				(31.8	)			75.4				77.5
Adjustments to EBITDA:
Restructuring charges			0.3				0.1				1.7				1.8				6.9
Environmental charges			0.5				0.2				2.3				2.8				2.3
Legal settlement			—				—				—				—				(0.5	)
Transaction costs			0.5				—				—				0.3				0.7
Inventory fair value step-up			0.6				—				—				—				—
Costs of tax improvement initiatives			—				—				—				—				0.1
Non-cash pension expense			—				1.9				132.4				2.5				0.8
Foreign currency (gain) loss			(0.3	)			1.3				3.3				(5.3	)			1.8
Total adjustments to EBITDA			1.7				3.5				139.7				2.1				12.0
Adjusted EBITDA		$	34.7			$	25.7			$	107.8			$	77.5			$	89.5
Net sales		$	147.7			$	128.4			$	512.9			$	424.1			$	469.0
Adjusted EBITDA as a % of net sales			23.5	%			20.0	%			21.0	%			18.3	%			19.1	%

Adjusted Net Earnings

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Net earnings (loss) (A)		$	20.2			$	12.0			$	(41.9	)		$	34.7			$	36.1
Adjustments to reported net earnings (loss):
Restructuring charges			0.3				0.1				1.7				1.8				7.4
Environmental charges			0.5				0.2				2.3				2.8				2.3
Legal settlement			—				—				—				—				(0.5	)
Transaction costs			0.5				—				—				0.3				0.7
Inventory fair value step-up			0.6				—				—				—				—
Costs of tax improvement initiatives			—				—				—				—				0.1
Non-cash pension expense			—				1.9				132.4				2.5				0.8
Foreign currency (gain) loss			(0.3	)			1.3				3.3				(5.3	)			1.8
Total adjustments to reported net earnings (loss)		$	1.7			$	3.5			$	139.7			$	2.1			$	12.6
Total adjustments, tax affected (B)		$	1.4			$	3.0			$	108.6			$	0.4			$	10.2
Tax adjustments:
Increase in valuation allowances			—				—				0.9				0.2				—
Other discrete tax items			—				—				(4.7	)			1.2				1.8
Total tax adjustments (C)		$	—			$	—			$	(3.8	)		$	1.4			$	1.8
Adjusted net earnings (A+B+C)		$	21.7			$	15.0			$	63.0			$	36.5			$	48.1
Net sales		$	147.7			$	128.4			$	512.9			$	424.1			$	469.0
Adjusted net earnings as a % of net sales			14.7	%			11.7	%			12.3	%			8.6	%			10.3	%

Adjusted Diluted Earnings Per Share

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
GAAP diluted earnings (loss) per share		$	0.63			$	0.37			$	(1.30	)		$	1.06			$	1.09
Tax affected charges to reported diluted earnings (loss) per share:
Restructuring charges			0.01				—				0.06				0.04				0.18
Foreign currency (gain) loss			(0.01	)			0.04				0.10				(0.16	)			0.05
Non-cash pension expense			—				0.04				3.13				0.06				0.02
Environmental charges			0.01				0.01				0.05				0.07				0.05
Transaction costs			0.02				—				—				0.01				0.02
Inventory fair value step-up			0.01				—				—				—				—
Legal settlement			—				—				—				—				(0.01	)
Discrete tax items			—				—				(0.11	)			0.04				0.05
Adjusted diluted earnings per share		$	0.67			$	0.46			$	1.93			$	1.12			$	1.45

Debt to Capitalization

	Three Months Ended March 31,								Twelve Months Ended December 31,
	2022				2021				2021				2020				2019
Total debt (A)	$	50.0			$	50.0			$	50.0			$	54.6			$	99.7
Total shareholders’ equity (B)	$	480.2			$	435.7			$	463.6			$	423.7			$	405.2
Total capitalization (A+B)	$	530.2			$	485.7			$	513.6			$	478.3			$	504.9
Total debt to capitalization		9.4	%			10.3	%			9.7	%			11.4	%			19.7	%

Controllable Working Capital

	Three Months Ended March 31,								Twelve Months Ended December 31,
	2022				2021				2021				2020				2019
Net accounts receivable	$	95.1			$	81.6			$	82.2			$	81.0			$	78.0
Net inventory	$	52.5			$	47.5			$	49.5			$	45.9			$	42.2
Accounts payable	$	(60.0	)		$	(53.3	)		$	(55.5	)		$	(50.5	)		$	(48.2	)
Controllable working capital	$	87.6			$	75.8			$	76.2			$	76.4			$	72.0
Quarter sales	$	147.7			$	128.4			$	132.5			$	123.0			$	115.0
Multiplied by 4		4				4				4				4				4
Annualized sales	$	590.8			$	513.6			$	530.1			$	492.1			$	460.2
Controllable working capital as a % of annualized net sales		14.8	%			14.8	%			14.4	%			15.5	%			15.7	%

Free Cash Flow

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Net cash provided by operating activities		$	19.3			$	20.1			$	86.1			$	76.8			$	64.4
Capital expenditures			(3.4	)			(1.6	)			(15.6	)			(14.9	)			(21.7	)
Free cash flow		$	15.9			$	18.5			$	70.5			$	61.9			$	42.7

Capital Expenditures

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Capital expenditures		$	3.4			$	1.6			$	15.6			$	14.9			$	21.7
Net sales		$	147.7			$	128.4			$	512.9			$	424.1			$	469.0
Capex as % of net sales			2.3	%			1.3	%			3.0	%			3.5	%			4.6	%

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

		Three Months Ended March 31,								Twelve Months Ended December 31,
		2022				2021				2021				2020				2019
Depreciation and amortization expense		$	6.7			$	6.8			$	26.9			$	26.7			$	24.6
Stock-based compensation expense		$	2.0			$	1.2			$	6.1			$	3.4			$	5.0

Disclaimer: This content is distributed by The GlobeNewswire